Elevance Health reaffirms FY26 earnings guidance
Elevance Health said it is standing by its full-year 2026 adjusted earnings floor of $20.10 per diluted share ahead of investor meetings. It also kept its adjusted earnings outlook above $27.00 per share and its benefit expense ratio target at 90.2%.